Table 1 Baseline characteristics in the control and treated groups
Variables | Total (n = 355) | Control (n = 174) | Treated (n = 181) |
|---|---|---|---|
Age (years), Median (Q1, Q3) | 68 (57, 79) | 67 (56, 78) | 69 (58.75, 79) |
Gender, male n (%) | 217 (61) | 104 (60) | 113 (62) |
Source of admission, n (%) | Â | Â | Â |
 Emergency room | 108 (30) | 52 (30) | 56 (31) |
 Other | 10 (3) | 2 (2) | 8 (5) |
 Postoperative | 114 (32) | 57 (33) | 57 (31) |
 Transfer from other hospital | 2 (1) | 2 (1) | 0 (0) |
 Ward | 121 (34) | 61 (35) | 60 (33) |
Type, n (%) | Â | Â | Â |
 Emergency operation | 109 (31) | 57 (33) | 52 (29) |
 Medical | 194 (55) | 91 (52) | 103 (57) |
 Optional operation | 52 (15) | 26 (15) | 26 (14) |
Comorbidity | Â | Â | Â |
 Diabetes, n (%) | 74 (21) | 40 (23) | 34 (19) |
 Hypertension, n (%) | 92 (26) | 46 (26) | 46 (26) |
 Myocardial infarction, n (%) | 14 (4) | 8 (5) | 6 (3) |
 Heart failure, n (%) | 22 (6) | 11 (6) | 11 (6) |
 Cerebrovascular, n (%) | 29 (8) | 17 (10) | 12 (7) |
 Dementia, n (%) | 11 (3) | 6 (3) | 5 (3) |
 COPD, n (%) | 23 (6) | 10 (6) | 13 (7) |
 Connective tissue, n (%) | 18 (5) | 9 (5) | 9 (5) |
 Paralysis, n (%) | 7 (2) | 4 (2) | 3 (2) |
 Renal failure, n (%) | 13 (4) | 7 (4) | 6 (3) |
 Malignancy, n (%) | 59 (17) | 33 (19) | 26 (14) |
 Hematological malignancy, n (%) | 8 (2) | 4 (2) | 4 (2) |
 Cirrhosis, n (%) | 11 (3) | 3 (2) | 8 (4) |
 Metastatic tumor, n (%) | 15 (4) | 8 (5) | 7 (4) |
 Immunosuppression, n (%) | 28 (8) | 17 (10) | 11 (6) |
Infection sites, n (%) | Â | Â | Â |
 Abdominal | 114 (32) | 61 (35) | 53 (29) |
 Bile duct | 24 (7) | 6 (3) | 18 (10) |
 Bloodstream | 21 (6) | 9 (5) | 12 (7) |
 CNS | 2 (1) | 2 (1) | 0 (0) |
 Gastrointestine | 9 (3) | 5 (3) | 4 (2) |
 Hemo | 4 (1) | 3 (2) | 1 (1) |
 Liver abscess | 3 (1) | 1 (1) | 2 (1) |
 Mediastinum | 1 (0) | 0 (0) | 1 (1) |
 Lower respiratory tract | 116 (33) | 63 (36) | 53 (29) |
 Skin | 10 (3) | 6 (3) | 4 (2) |
 Thoracic | 3 (1) | 1 (1) | 2 (1) |
 Unknown | 14 (4) | 5 (3) | 9 (5) |
 Urinary tract | 34 (10) | 12 (7) | 22 (12) |
SOFA, median (Q1, Q3) | 8 (5, 11) | 8 (6, 11) | 8 (5, 10) |
GCS, median (Q1, Q3) | 14 (11, 15) | 14 (11, 15) | 15 (11, 15) |
MV, n (%) | 177 (51) | 94 (54) | 83 (47) |
CRRT, n (%) | 26 (7) | 14 (8) | 12 (7) |